This template supports delivery of:
NHS Cervical Screening Programme
QOF Indicator CS005 – for recording invitations and non-responders
Local Enhanced Services (LES) where smear taking attracts an additional payment
It also ensures safe, compliant clinical practice through clear documentation of eligibility, consent, and exclusions.
Eligible patients:
Aged 25–49: Invited every 3 years
Aged 50–64: Invited every 5 years
Patients under 25 are only screened if:
Clinically indicated (e.g. persistent abnormal bleeding)
Within 12 weeks of childbirth or pregnancy loss, as per guidance
The template supports:
Smear documentation
Consent confirmation
Symptom screening
Coding of decline/refusal
Embedded guidance on age and timing of invitations
Reminder: avoid smear during menstruation or if lubricants/oestrogen creams used in last 48 hrs
Records method:
Combined pill
POP
Depo
IUD
Implant
Useful for risk profiling and correlation with HPV vaccination
Tick if patient has received HPV vaccine
Helps with audit and risk stratification
Document parity and gravidity (automatically informs likelihood of cervical cell changes)
Record gynaecological symptoms:
Bleeding
Discharge
Irritation
Confirm absence of interfering factors:
Lubricant or oestrogen use within 2 days
Rebooking advised if recently used
Last menstrual period recorded
Confirm:
Consent for smear
Consent for HPV testing
Tick if screening declined (ensures appropriate exemption coding)
Use this during routine invites or opportunistic screening
If the patient declines or defers, use SNOMED-coded decline options to avoid QOF shortfall
HPV testing consent is critical for programme compliance — tick only when patient understands
Avoid smears:
During menstruation
<12 weeks postnatal unless urgent
Within 48 hrs of vaginal creams/lubricants
If patient symptomatic, refer — cervical screening is not diagnostic